Allarity Therapeutics (ALLR) stock forecast for 2026. Forecast tables and graphs.







Buy or Sell AAPL stocks? (AAPL) forecasting

Apple: Much To Prove In 2025

December 12, 2024
When to Switch Payroll Solutions and How to Make a Smooth Transition

December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition

Payroll solutions are important for every business, as without them, you cannot make the right choices and calculations in your payment system. However,…
Latest Finance Management Regulations in Australia

November 24, 2024 Latest Finance Management Regulations in Australia

Navigating the maze of Finance Regulations can feel like trying to solve a puzzle without all the pieces. Just when you think you’ve…
Finance Management Education Resources

November 24, 2024 Finance Management Education Resources

Trying to manage money without guidance can feel like wrestling an octopus—in the dark. You’re sifting through credit card offers, debating investment options,…
Best Forex Trading Tools

November 18, 2024 Best Forex Trading Tools

Selecting the ideal Forex Trading Tools can feel like trying to solve a jigsaw puzzle without the picture—overwhelming, right? So many options, each…
Best Backtesting Software For Traders

November 18, 2024 Best Backtesting Software For Traders

Trading isn’t merely about numbers flickering on a screen; it’s a dynamic journey fraught with challenges and discoveries. I remember countless nights poring…

Allarity Therapeutics (ALLR) stock forecast for 2026

Updated: December 12, 2024 (19:36)

Sector: Healthcare

The share price of Allarity Therapeutics, Inc. (ALLR) now

What analysts predict: $5
52-week High/Low: $378.0 / $1

50/200 Day Moving Average: $2.206 / $64.88

This figure corresponds to the Average Price over the previous 50/200 days. For Allarity Therapeutics stocks, the 50-day moving average is the resistance level today.

For Allarity Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Allarity Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allarity Therapeutics stock price in 2026. How much will one Allarity Therapeutics share be worth in 2026? Is it worth taking profit / loss on ALLR stock now or waiting? What are analysts' forecasts for Allarity Therapeutics stock?

We forecast Allarity Therapeutics stock performance using neural networks based on historical data on ALLR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Allarity Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Allarity Therapeutics analysts is $5. Today 200 Day Moving Average is the resistance level (64.88 $). 50 Day Moving Average is the resistance level (2.206 $).




Historical and forecast chart of Allarity Therapeutics, Inc. stock

The chart below shows the historical price of Allarity Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ALLR stock price can be found in the table below.


Allarity Therapeutics is a late clinical-stage, precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers guided by its proprietary drug response predictor technology, the DRP platform.

Trending Themes in the Healthcare Sector

Allarity Therapeutics (ALLR) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 0.03 -0.03 0.07 144.41 %
Feb 0.00 0.00 0.00 1,546.66 %
Mar 0.00 0.00 0.00 1,269.56 %
Apr 0.00 -0.01 0.00 372.79 %
May -0.01 -0.02 0.00 890.32 %
Jun -0.04 -0.08 -0.01 536.58 %
Jul -0.06 -0.11 0.01 2,290.92 %
Aug 0.12 0.00 0.41 98.79 %
Sep -0.01 -0.05 0.02 364.07 %
Oct 0.00 0.00 0.01 106.15 %
Nov 0.00 0.00 0.00 238.99 %
Dec -0.01 -0.03 0.01 509.47 %

Allarity Therapeutics information and performance

Allarity Therapeutics Address

210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US

Market Capitalization: 2 062 500 $

Market capitalization of the Allarity Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALLR shares in the company outstanding by the market price of one share.

EBITDA: -16 895 000 $

EBITDA of Allarity Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -10.98

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.0842

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1412600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Allarity Therapeutics price target for 2026 by month


Target values for the price of one Allarity Therapeutics share for Jan 2026.

The weighted average target price per Allarity Therapeutics share in Jan 2026 is: 0.03.
In Jan, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 144.409% volatility is expected.
Pessimistic target level: -0.03
Optimistic target level: 0.07

Target values for the price of one Allarity Therapeutics share for Feb 2026.

The weighted average target price per Allarity Therapeutics share in Feb 2026 is: 0.00.
In Feb, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 1,546.663% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Allarity Therapeutics share for Mar 2026.

The weighted average target price per Allarity Therapeutics share in Mar 2026 is: 0.00.
In Mar, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 1,269.564% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Allarity Therapeutics share for Apr 2026.

The weighted average target price per Allarity Therapeutics share in Apr 2026 is: 0.00.
In Apr, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 372.789% volatility is expected.
Pessimistic target level: -0.01
Optimistic target level: 0.00

Target values for the price of one Allarity Therapeutics share for May 2026.

The weighted average target price per Allarity Therapeutics share in May 2026 is: -0.01.
In May, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 890.322% volatility is expected.
Pessimistic target level: -0.02
Optimistic target level: 0.00

Target values for the price of one Allarity Therapeutics share for Jun 2026.

The weighted average target price per Allarity Therapeutics share in Jun 2026 is: -0.04.
In Jun, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 536.585% volatility is expected.
Pessimistic target level: -0.08
Optimistic target level: -0.01

Target values for the price of one Allarity Therapeutics share for Jul 2026.

The weighted average target price per Allarity Therapeutics share in Jul 2026 is: -0.06.
In Jul, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 2,290.920% volatility is expected.
Pessimistic target level: -0.11
Optimistic target level: 0.01

Target values for the price of one Allarity Therapeutics share for Aug 2026.

The weighted average target price per Allarity Therapeutics share in Aug 2026 is: 0.12.
In Aug, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 98.789% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.41

Target values for the price of one Allarity Therapeutics share for Sep 2026.

The weighted average target price per Allarity Therapeutics share in Sep 2026 is: -0.01.
In Sep, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 364.072% volatility is expected.
Pessimistic target level: -0.05
Optimistic target level: 0.02

Target values for the price of one Allarity Therapeutics share for Oct 2026.

The weighted average target price per Allarity Therapeutics share in Oct 2026 is: 0.00.
In Oct, the Positive dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 106.149% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.01

Target values for the price of one Allarity Therapeutics share for Nov 2026.

The weighted average target price per Allarity Therapeutics share in Nov 2026 is: 0.00.
In Nov, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 238.993% volatility is expected.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Target values for the price of one Allarity Therapeutics share for Dec 2026.

The weighted average target price per Allarity Therapeutics share in Dec 2026 is: -0.01.
In Dec, the Negative dynamics for Allarity Therapeutics, Inc. shares will prevail with possible monthly volatility of 509.474% volatility is expected.
Pessimistic target level: -0.03
Optimistic target level: 0.01



Related stocks from Healthcare sector


Disclaimer: